An invited review of the available literature on migraine and its impact on testing for glaucoma was published in 2016.
The first patient has been enrolled in a prospective, randomised, multicentre study to investigate canaloplasty with the new iTrack Advance CATALYST Study.
Given the convincing findings from the Age-Related Eye Disease Study (AREDS) on supplement recommendations in slowing down progression of age-related macular degeneration (AMD), it is not surprising that the role of diet and supplements has also been examined in glaucoma management.
In this study, researchers are testing an investigational drug for adults with ocular hypertension.
A new, detailed genetic roadmap of glaucoma, revealed by Australian ophthalmologist Professor Alex Hewitt, will help researchers develop new drugs to combat the disease, by identifying potential target areas to stall or reverse vision loss.
Scientists are examining key elements of the complex transport system that moves important molecules between the retina and the brain via the optic nerve…
The question of whether sleep apnoea is a risk factor for glaucoma was recently debated in a session at the 2021 World Glaucoma Congress...
Despite increasingly advanced treatments and early intervention, parents and carers, some of whom have been diagnosed with genetic glaucoma themselves, face significant long-term challenges...
Dr Georgie Hollitt is part of a team of Australian researchers who have identified 107 genes that increase the risk of glaucoma...